Cysticercosis: Clinical Trials

3 trials for Cysticercosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 terminated. 3 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Terminated 1
Phase 33Completed 1, Not yet recruiting 1, Terminated 1

Follow Cysticercosis: new trials by email Literature Review of Cysticercosis trials Research Report on Cysticercosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oxfendazole in Mild Parenchymal Brain Cysticercosis
Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis
Phase 2 / Phase 3Not yet recruitingUniversidad Peruana Cayetano Heredia5442026-12-012026-05-01
Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)
Acetazolamide, Dexamethasone - Neurocysticercosis
Phase 2 / Phase 3TerminatedUniversidad Peruana Cayetano Heredia42015-12-042025-04-01
Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
Praziquantel, Albendazole, ABZ Placebo - Neurocysticercosis, Epilepsy
Phase 2 / Phase 3CompletedUniversidad Peruana Cayetano Heredia1562010-01-012015-06-11

Narrower conditions

Neurocysticercosis (3)  ·  Epilepsy (1)  ·  Taeniasis (1)

Broader conditions

Central Nervous System Diseases (3)  ·  Central Nervous System Helminthiasis (3)  ·  Central Nervous System Infections (3)  ·  Central Nervous System Parasitic Infections (3)  ·  Cestode Infections (3)  ·  Helminthiasis (3)  ·  Infections (3)  ·  Nervous System Diseases (3)  ·  Parasitic Diseases (3)  ·  Taeniasis (2)  ·  Brain Diseases (1)

Interventions

Albendazole (2)  ·  Acetazolamide (1)  ·  Dexamethasone (1)  ·  Praziquantel (1)  ·  oxfendazole (1)

Sponsors

Universidad Peruana Cayetano Heredia (3)

Countries

Peru (2)

Top investigators

E. Javier Pretell, MD (1)  ·  Hector H Garcia, MD, PhD (1)  ·  Hector H. Garcia, MD (1)  ·  Hector H. Garcia, MD, PhD (1)  ·  Javier A. Bustos, MD (1)

Results publications

PMID 21332573, PMID 24999157, PMID 26984901

NIH funding

R01NS054805 (1)